Epidemiology and outcomes research for MGUS, myeloma and amyloidosis
- 31 July 2006
- journal article
- review article
- Published by Elsevier BV in European Journal of Cancer
- Vol. 42 (11), 1671-1683
- https://doi.org/10.1016/j.ejca.2006.01.065
Abstract
No abstract availableThis publication has 102 references indexed in Scilit:
- Association between obesity and multiple myeloma in postmenopausal women may be attributed to increased aromatization of androgen in adipose tissueMedical Hypotheses, 2005
- Risk-adjusted manipulation of melphalan dose before stem cell transplantation in patients with amyloidosis is associated with a lower response rateBone Marrow Transplantation, 2004
- Immunomodulatory Analogs of Thalidomide: An Emerging New Therapy in MyelomaJournal of Clinical Oncology, 2004
- Single versus Double Autologous Stem-Cell Transplantation for Multiple MyelomaThe New England Journal of Medicine, 2003
- High-dose intravenous melphalan and autologous stem cell transplantation as initial therapy or following two cycles of oral chemotherapy for the treatment of AL amyloidosis: results of a prospective randomized trialBone Marrow Transplantation, 2003
- A Long-Term Study of Prognosis in Monoclonal Gammopathy of Undetermined SignificanceThe New England Journal of Medicine, 2002
- Bone marrow angiogenesis and progression in multiple myelomaBritish Journal of Haematology, 1994
- Benzene and LeukemiaThe New England Journal of Medicine, 1987
- Comparison of Trends in the Incidence of Multiple Myeloma in Malmö, Sweden, and Other Countries, 1950–1979The New England Journal of Medicine, 1984
- Smoldering Multiple MyelomaThe New England Journal of Medicine, 1980